trending Market Intelligence /marketintelligence/en/news-insights/trending/ArdrUpAyPGZioTXj88RdiA2 content esgSubNav
In This List

Aerie Pharmaceuticals closes stock offering

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


Aerie Pharmaceuticals closes stock offering

Aerie Pharmaceuticals Inc. closed an underwritten public offering of 1,395,349 common shares at $53.75 apiece for net proceeds of about $72.4 million.

The company also sold 906,858 common shares via an at-the-market program for another $50 million.

Cantor Fitzgerald & Co. acted as the sole book runner for both transactions.